Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Equity Ratio: 2009-2021

Historic Equity Ratio for Avadel Pharmaceuticals (AVDL) over the last 13 years, with Dec 2021 value amounting to 0.32.

  • Avadel Pharmaceuticals' Equity Ratio fell 122.78% to -0.09 in Q3 2022 from the same period last year, while for Sep 2022 it was -0.09, marking a year-over-year decrease of 122.78%. This contributed to the annual value of 0.32 for FY2021, which is 39.23% down from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Equity Ratio stood at 0.32 for FY2021, which was down 39.23% from 0.52 recorded in FY2020.
  • Avadel Pharmaceuticals' 5-year Equity Ratio high stood at 0.52 for FY2020, and its period low was -0.19 during FY2019.
  • Over the past 3 years, Avadel Pharmaceuticals' median Equity Ratio value was 0.32 (recorded in 2021), while the average stood at 0.21.
  • As far as peak fluctuations go, Avadel Pharmaceuticals' Equity Ratio plummeted by 1,419.88% in 2019, and later spiked by 370.05% in 2020.
  • Yearly analysis of 5 years shows Avadel Pharmaceuticals' Equity Ratio stood at 0.34 in 2017, then crashed by 95.68% to 0.01 in 2018, then plummeted by 1,419.88% to -0.19 in 2019, then spiked by 370.05% to 0.52 in 2020, then slumped by 39.23% to 0.32 in 2021.